MA26659A1 - Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. - Google Patents

Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.

Info

Publication number: MA26659A1
Authority: MA; Morocco
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; benzimidazole derivatives; novel benzimidazole
Prior art date: 1998-08-06

Application number

MA25646A

Other languages

English (en)

Inventor

Ito Fumitaka

Kondo Hiroshi

Noguchi Hirohide

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-06

Filing date

1999-06-25

Publication date

2004-12-20

1999-06-25 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26659A1 publication Critical patent/MA26659A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MA25646A 1998-08-06 1999-06-25 Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. MA26659A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IBPCT/IB98/01206		1998-08-06

Publications (1)

Publication Number	Publication Date
MA26659A1 true MA26659A1 (fr)	2004-12-20

Family

ID=11004738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25646A MA26659A1 (fr)	1998-08-06	1999-06-25	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.

Country Status (44)

Country	Link
US (1)	US6172067B1 (fr)
EP (1)	EP1102762B1 (fr)
JP (1)	JP3367945B2 (fr)
CN (1)	CN1317968A (fr)
AP (1)	AP2001002063A0 (fr)
AR (1)	AR018686A1 (fr)
AT (1)	ATE227716T1 (fr)
AU (1)	AU749166B2 (fr)
BG (1)	BG105301A (fr)
BR (1)	BR9912778A (fr)
CA (1)	CA2339621C (fr)
CZ (1)	CZ2001397A3 (fr)
DE (1)	DE69903953T2 (fr)
DK (1)	DK1102762T3 (fr)
EA (1)	EA200100104A1 (fr)
EE (1)	EE200100075A (fr)
ES (1)	ES2185357T3 (fr)
GE (1)	GEP20033000B (fr)
GT (1)	GT199900125A (fr)
HK (1)	HK1040188A1 (fr)
HN (1)	HN1999000105A (fr)
HR (1)	HRP20010089B1 (fr)
HU (1)	HUP0103567A3 (fr)
ID (1)	ID27212A (fr)
IL (1)	IL141029A0 (fr)
IS (1)	IS5812A (fr)
MA (1)	MA26659A1 (fr)
NO (1)	NO20010603L (fr)
NZ (1)	NZ509299A (fr)
OA (1)	OA11590A (fr)
PA (1)	PA8477701A1 (fr)
PE (1)	PE20000868A1 (fr)
PL (1)	PL346211A1 (fr)
PT (1)	PT1102762E (fr)
SI (1)	SI1102762T1 (fr)
SK (1)	SK1602001A3 (fr)
SV (1)	SV1999000099A (fr)
TN (1)	TNSN99142A1 (fr)
TR (1)	TR200100403T2 (fr)
TW (1)	TW513424B (fr)
UY (1)	UY25659A1 (fr)
WO (1)	WO2000008013A2 (fr)
YU (1)	YU8201A (fr)
ZA (1)	ZA200100900B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6340681B1 (en) *	1999-07-16	2002-01-22	Pfizer Inc	2-benzimidazolylamine compounds as ORL-1-receptor agonists
SE9902987D0 (sv)	1999-08-24	1999-08-24	Astra Pharma Prod	Novel compounds
SE9903544D0 (sv)	1999-10-01	1999-10-01	Astra Pharma Prod	Novel compounds
EP1122257B1 (fr)	2000-01-05	2005-10-12	Pfizer Inc.	Composés de benzimidazole comme agonistes du récepteur ORL1
GB2359081A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active thiazolopyrimidines
GB2359078A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB2359551A (en)	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en)	2000-03-10	2000-05-03	Astrazeneca Uk Ltd	Chemical compounds
SE0003828D0 (sv)	2000-10-20	2000-10-20	Astrazeneca Ab	Novel compounds
JP4155029B2 (ja)	2000-11-15	2008-09-24	萬有製薬株式会社	ベンズイミダゾール誘導体
GB0104050D0 (en)	2001-02-19	2001-04-04	Astrazeneca Ab	Chemical compounds
GB0107228D0 (en)	2001-03-22	2001-05-16	Astrazeneca Ab	Chemical compounds
SE0101322D0 (sv)	2001-04-12	2001-04-12	Astrazeneca Ab	Novel compounds
KR100855204B1 (ko) *	2001-04-18	2008-09-01	유로-셀티크 소시에떼 아노뉨	노시셉틴 유사체
CZ20032849A3 (en)	2001-04-18	2004-03-17	Euro-Celtique S.A.	Spiropyrazole compounds
PT1975164E (pt) *	2001-04-18	2010-04-20	Euro Celtique Sa	Compostos de octa-hidrobenzimidazolona utilizados como analgésicos
ATE423098T1 (de)	2001-04-18	2009-03-15	Euro Celtique Sa	1-(4-piperidinyl)-1,3-dihydro-2h-indol-2-on derivate und verwandte verbindungen als nociceptin analoge und orl1 liganden zur behandlung von schmerz
SI1385514T1 (sl)	2001-04-18	2009-04-30	Euro Celtique Sa	Spiroindenske in spiroindanske spojine
JP2005502619A (ja) *	2001-07-02	2005-01-27	オメロスコーポレイション	オピオイドレセプター様レセプター１アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法
US20030040479A1 (en) *	2001-07-02	2003-02-27	Omeros Corporation	Rotational intrathecal analgesia method and device
SE0102716D0 (sv) *	2001-08-14	2001-08-14	Astrazeneca Ab	Novel compounds
SE0103818D0 (sv)	2001-11-15	2001-11-15	Astrazeneca Ab	Chemical compounds
US7812035B2 (en) *	2001-12-11	2010-10-12	Sepracor Inc.	4-substituted piperidines, and methods of use thereof
DK1491212T3 (da)	2002-03-29	2012-10-29	Mitsubishi Tanabe Pharma Corp	Middel til behandling af søvnforstyrrelser
GB0221828D0 (en)	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
GB0221829D0 (en) *	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
DE10252665A1 (de) *	2002-11-11	2004-06-03	Grünenthal GmbH	4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
DE10252666A1 (de) *	2002-11-11	2004-08-05	Grünenthal GmbH	N-Piperidyl-cyclohexan-Derivate
SE0301369D0 (sv)	2003-05-09	2003-05-09	Astrazeneca Ab	Chemical compounds
GB0315203D0 (en) *	2003-06-28	2003-08-06	Celltech R&D Ltd	Chemical compounds
SA04250305B1 (ar)	2003-09-25	2008-06-02	سولفاي فارماسوتيكالز بي . في	مشتقات بنزيميدازولون cenzimidazolone وكينازولينون quinazolinone كمساعادات على مستقبلات ORL1 البشرية
GB0328243D0 (en) *	2003-12-05	2004-01-07	Astrazeneca Ab	Methods
WO2005060947A2 (fr) *	2003-12-19	2005-07-07	Sri International	Ligands agonistes et antagonistes du recepteur de la nociceptine
WO2006038738A1 (fr) *	2004-10-08	2006-04-13	Takeda Pharmaceutical Company Limited	Agent de régulation du fonctionnement d'un récepteur
ATE488235T1 (de)	2005-01-11	2010-12-15	Neurosearch As	Neue 2-amino-benzimidazolderivate und ihre verwendung als modulatoren calciumaktivierter kaliumkanäle mit geringer leitfähigkeit
WO2008003667A2 (fr) *	2006-07-03	2008-01-10	Neurosearch A/S	Compositions pharmaceutiques
NZ601683A (en) *	2007-01-16	2012-11-30	Shionogi & Co	Heterocyclic-substituted piperidine compounds for modulating ORL-1 receptor function in a cell
KR20120102172A (ko) *	2007-08-31	2012-09-17	시오노기세이야쿠가부시키가이샤	치환-퀴녹살린-형 피페리딘 화합물 및 그의 용도
US8119661B2 (en) *	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
PL2324013T6 (pl)	2008-07-21	2015-11-30	Purdue Pharma Lp	Zmostkowane związki piperydyny typu podstawionej chinoksaliny oraz ich zastosowania
WO2012018668A1 (fr)	2010-08-05	2012-02-09	Amgen Inc.	Composés benzimidazole et azabenzimidazole qui inhibent la kinase des lymphomes anaplasiques
WO2013103598A2 (fr)	2012-01-06	2013-07-11	Novus International Inc.	Agents tensio-actifs à base de sulfoxyde
EP2812313A4 (fr)	2012-02-09	2015-09-30	Novus Int Inc	Compositions de polymères fonctionnalisés
JO3300B1 (ar)	2012-06-06	2018-09-16	Novartis Ag	مركبات وتركيبات لتعديل نشاط egfr
US9452143B2 (en)	2012-07-12	2016-09-27	Novus International, Inc.	Matrix and layer compositions for protection of bioactives
US9085561B2 (en) *	2012-07-30	2015-07-21	Purdue Pharma L.P.	Cyclic urea- or lactam-substituted quinoxaline-type piperidines as ORL-1 modulators
US9090618B2 (en)	2012-12-27	2015-07-28	Purdue Pharma L.P.	Substituted benzimidazole-type piperidine compounds and uses thereof
US9656994B2 (en)	2013-03-22	2017-05-23	The Scripps Research Institute	Substituted benzimidazoles as nociceptin receptor modulators
WO2015143148A1 (fr)	2014-03-20	2015-09-24	Capella Therapeutics, Inc.	Dérivés de benzimidazole en tant qu'inhibiteurs de la tyrosine kinase erbb pour le traitement du cancer
US10227551B2 (en)	2015-11-12	2019-03-12	Novus International, Inc.	Sulfur-containing compounds as solvents
US10584306B2 (en)	2017-08-11	2020-03-10	Board Of Regents Of The University Of Oklahoma	Surfactant microemulsions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3318900A (en) *	1964-05-06	1967-05-09	Janssen Pharmaceutica Nv	Derivatives of benzimidazolinyl piperidine
JPS5297978A (en) *	1976-06-02	1977-08-17	Yoshitomi Pharmaceut Ind Ltd	Preparation of alicyclic derivatives
US5821219A (en)	1995-08-11	1998-10-13	Oregon Health Sciences University	Opioid antagonists and methods of their use
WO1997007208A1 (fr)	1995-08-15	1997-02-27	Universite Libre De Bruxelles	Molecules d'acide nucleique codant des peptides presentant des proprietes pronociceptives
US5866346A (en)	1995-09-27	1999-02-02	Indiana Unversity Foundation	Methods of using dynorphins as ligands for XOR1 receptor
DE69736776T2 (de) *	1996-04-19	2007-01-18	Neurosearch A/S	1-(4-piperidyl)-benzimidazole mit neurotropher aktivität
EP0813065A3 (fr)	1996-06-13	1998-07-22	F. Hoffmann-La Roche Ag	Modulation de la fonction d'un récepteur LC-132(analogue à opioide)
EP0829481A1 (fr) *	1996-09-16	1998-03-18	Pfizer Inc.	Dérivés de l'acide morphinane hydroxamique
US5718912A (en) *	1996-10-28	1998-02-17	Merck & Co., Inc.	Muscarine agonists
JP4366532B2 (ja)	1997-05-30	2009-11-18	萬有製薬株式会社	２−オキソイミダゾール誘導体
WO1999003880A1 (fr)	1997-07-15	1999-01-28	Novo Nordisk A/S	Analogues de nociceptine
US5929035A (en)	1998-04-14	1999-07-27	Regents Of The University Of Michigan	Methods of treating intestinal disorders
ID29137A (id)	1998-07-27	2001-08-02	Schering Corp	Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1

1999
- 1999-06-25 MA MA25646A patent/MA26659A1/fr unknown
- 1999-06-28 TW TW088110899A patent/TW513424B/zh not_active IP Right Cessation
- 1999-07-05 EA EA200100104A patent/EA200100104A1/ru unknown
- 1999-07-05 PT PT99926688T patent/PT1102762E/pt unknown
- 1999-07-05 DE DE69903953T patent/DE69903953T2/de not_active Expired - Fee Related
- 1999-07-05 EP EP99926688A patent/EP1102762B1/fr not_active Expired - Lifetime
- 1999-07-05 SK SK160-2001A patent/SK1602001A3/sk unknown
- 1999-07-05 WO PCT/IB1999/001239 patent/WO2000008013A2/fr not_active Ceased
- 1999-07-05 HN HN1999000105A patent/HN1999000105A/es unknown
- 1999-07-05 OA OA1200100031A patent/OA11590A/en unknown
- 1999-07-05 ES ES99926688T patent/ES2185357T3/es not_active Expired - Lifetime
- 1999-07-05 NZ NZ509299A patent/NZ509299A/en not_active Application Discontinuation
- 1999-07-05 ID IDW20010284D patent/ID27212A/id unknown
- 1999-07-05 DK DK99926688T patent/DK1102762T3/da active
- 1999-07-05 CZ CZ2001397A patent/CZ2001397A3/cs unknown
- 1999-07-05 IL IL14102999A patent/IL141029A0/xx unknown
- 1999-07-05 HU HU0103567A patent/HUP0103567A3/hu unknown
- 1999-07-05 BR BR9912778-4A patent/BR9912778A/pt not_active Application Discontinuation
- 1999-07-05 TN TNTNSN99142A patent/TNSN99142A1/fr unknown
- 1999-07-05 JP JP2000563646A patent/JP3367945B2/ja not_active Expired - Fee Related
- 1999-07-05 HR HR970081A patent/HRP20010089B1/xx not_active IP Right Cessation
- 1999-07-05 SI SI9930151T patent/SI1102762T1/xx unknown
- 1999-07-05 CA CA002339621A patent/CA2339621C/fr not_active Expired - Fee Related
- 1999-07-05 YU YU8201A patent/YU8201A/sh unknown
- 1999-07-05 GE GEAP19995740A patent/GEP20033000B/en unknown
- 1999-07-05 HK HK02101444.8A patent/HK1040188A1/zh unknown
- 1999-07-05 TR TR2001/00403T patent/TR200100403T2/xx unknown
- 1999-07-05 AU AU43859/99A patent/AU749166B2/en not_active Ceased
- 1999-07-05 AP APAP/P/2001/002063A patent/AP2001002063A0/en unknown
- 1999-07-05 AT AT99926688T patent/ATE227716T1/de not_active IP Right Cessation
- 1999-07-05 EE EEP200100075A patent/EE200100075A/xx unknown
- 1999-07-05 CN CN99810857A patent/CN1317968A/zh active Pending
- 1999-07-05 PL PL99346211A patent/PL346211A1/xx not_active Application Discontinuation
- 1999-07-06 AR ARP990103264A patent/AR018686A1/es active IP Right Grant
- 1999-07-15 PE PE1999000717A patent/PE20000868A1/es not_active Application Discontinuation
- 1999-07-16 SV SV1999000099A patent/SV1999000099A/es not_active Application Discontinuation
- 1999-07-16 PA PA19998477701A patent/PA8477701A1/es unknown
- 1999-08-05 US US09/369,208 patent/US6172067B1/en not_active Expired - Fee Related
- 1999-08-06 GT GT199900125A patent/GT199900125A/es unknown
- 1999-08-13 UY UY25659A patent/UY25659A1/es not_active Application Discontinuation
2001
- 2001-01-16 IS IS5812A patent/IS5812A/is unknown
- 2001-02-01 ZA ZA200100900A patent/ZA200100900B/xx unknown
- 2001-02-05 NO NO20010603A patent/NO20010603L/no not_active Application Discontinuation
- 2001-03-01 BG BG105301A patent/BG105301A/xx unknown

Also Published As

Publication number	Publication date
OA11590A (en)	2004-08-18
AU4385999A (en)	2000-02-28
DK1102762T3 (da)	2002-12-16
DE69903953T2 (de)	2003-03-27
HUP0103567A2 (hu)	2002-02-28
JP3367945B2 (ja)	2003-01-20
HUP0103567A3 (en)	2003-01-28
EE200100075A (et)	2002-06-17
US6172067B1 (en)	2001-01-09
PT1102762E (pt)	2003-02-28
HN1999000105A (es)	2000-11-11
BR9912778A (pt)	2001-09-25
YU8201A (sh)	2003-07-07
SI1102762T1 (en)	2003-04-30
AR018686A1 (es)	2001-11-28
AU749166B2 (en)	2002-06-20
NO20010603D0 (no)	2001-02-05
GEP20033000B (en)	2003-06-25
WO2000008013A3 (fr)	2000-03-23
CA2339621A1 (fr)	2000-02-17
EP1102762A2 (fr)	2001-05-30
WO2000008013A2 (fr)	2000-02-17
HK1040188A1 (zh)	2002-05-31
EA200100104A1 (ru)	2001-08-27
UY25659A1 (es)	2000-02-23
NO20010603L (no)	2001-04-05
CN1317968A (zh)	2001-10-17
ZA200100900B (en)	2002-08-28
ES2185357T3 (es)	2003-04-16
TNSN99142A1 (fr)	2005-11-10
BG105301A (en)	2001-12-29
NZ509299A (en)	2003-05-30
JP2002522431A (ja)	2002-07-23
IS5812A (is)	2001-01-16
HRP20010089B1 (en)	2003-04-30
GT199900125A (es)	2001-01-27
EP1102762B1 (fr)	2002-11-13
HRP20010089A2 (en)	2002-02-28
ATE227716T1 (de)	2002-11-15
PL346211A1 (en)	2002-01-28
PE20000868A1 (es)	2000-08-31
TR200100403T2 (tr)	2001-07-23
IL141029A0 (en)	2002-02-10
AP2001002063A0 (en)	2001-03-31
SV1999000099A (es)	2000-09-05
CA2339621C (fr)	2005-04-05
PA8477701A1 (es)	2000-09-29
TW513424B (en)	2002-12-11
DE69903953D1 (de)	2002-12-19
CZ2001397A3 (cs)	2002-05-15
SK1602001A3 (en)	2002-09-10
ID27212A (id)	2001-03-08

Publication	Publication Date	Title
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3045A1 (fr)	2004-03-27	Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3009A1 (fr)	2004-03-27	Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2198A1 (fr)	2002-12-02	Dérivés de lactames, procédé pour leur préparationet compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2634A1 (fr)	2003-03-08	Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
DZ3020A1 (fr)	2004-03-20	Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2870A1 (fr)	2003-12-15	Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant.
DZ2889A1 (fr)	2003-12-15	4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2217A1 (fr)	2002-12-03	Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.